CG Oncology, Inc. Common stockCGONNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+576.6%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+576.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
309.8x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$4.65M-
2024$0.00-
2023$0.00-100.0%
2022$15000.00+50.0%
2021$10000.00-